These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27185156)

  • 1. Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes.
    Tuomi T; Nagorny CLF; Singh P; Bennet H; Yu Q; Alenkvist I; Isomaa B; Östman B; Söderström J; Pesonen AK; Martikainen S; Räikkönen K; Forsén T; Hakaste L; Almgren P; Storm P; Asplund O; Shcherbina L; Fex M; Fadista J; Tengholm A; Wierup N; Groop L; Mulder H
    Cell Metab; 2016 Jun; 23(6):1067-1077. PubMed ID: 27185156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.
    Lyssenko V; Nagorny CL; Erdos MR; Wierup N; Jonsson A; Spégel P; Bugliani M; Saxena R; Fex M; Pulizzi N; Isomaa B; Tuomi T; Nilsson P; Kuusisto J; Tuomilehto J; Boehnke M; Altshuler D; Sundler F; Eriksson JG; Jackson AU; Laakso M; Marchetti P; Watanabe RM; Mulder H; Groop L
    Nat Genet; 2009 Jan; 41(1):82-8. PubMed ID: 19060908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disentangling the Role of Melatonin and its Receptor MTNR1B in Type 2 Diabetes: Still a Long Way to Go?
    Bonnefond A; Froguel P
    Curr Diab Rep; 2017 Oct; 17(12):122. PubMed ID: 29063374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin signalling and type 2 diabetes risk: too little, too much or just right?
    Mulder H
    Diabetologia; 2017 May; 60(5):826-829. PubMed ID: 28303303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of melatonin in diabetes: therapeutic implications.
    Sharma S; Singh H; Ahmad N; Mishra P; Tiwari A
    Arch Endocrinol Metab; 2015 Oct; 59(5):391-9. PubMed ID: 26331226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in MTNR1B affecting insulin secretion.
    Müssig K; Staiger H; Machicao F; Häring HU; Fritsche A
    Ann Med; 2010 Sep; 42(6):387-93. PubMed ID: 20597807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin receptors in diabetes: a potential new therapeutical target?
    She M; Laudon M; Yin W
    Eur J Pharmacol; 2014 Dec; 744():220-3. PubMed ID: 25160745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene.
    Mulder H; Nagorny CL; Lyssenko V; Groop L
    Diabetologia; 2009 Jul; 52(7):1240-9. PubMed ID: 19377888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes.
    Huopio H; Cederberg H; Vangipurapu J; Hakkarainen H; Pääkkönen M; Kuulasmaa T; Heinonen S; Laakso M
    Eur J Endocrinol; 2013 Sep; 169(3):291-7. PubMed ID: 23761423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The associations of daylight and melatonin receptor 1B gene rs10830963 variant with glycemic traits: the prospective PPP-Botnia study.
    Haljas K; Hakaste L; Lahti J; Isomaa B; Groop L; Tuomi T; Räikkönen K
    Ann Med; 2019 Feb; 51(1):58-67. PubMed ID: 30592226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin influences insulin secretion primarily via MT(1) receptors in rat insulinoma cells (INS-1) and mouse pancreatic islets.
    Mühlbauer E; Albrecht E; Bazwinsky-Wutschke I; Peschke E
    J Pineal Res; 2012 May; 52(4):446-59. PubMed ID: 22288848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes.
    Rosengren AH; Jokubka R; Tojjar D; Granhall C; Hansson O; Li DQ; Nagaraj V; Reinbothe TM; Tuncel J; Eliasson L; Groop L; Rorsman P; Salehi A; Lyssenko V; Luthman H; Renström E
    Science; 2010 Jan; 327(5962):217-20. PubMed ID: 19965390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
    Hu C; Zhang R; Wang C; Yu W; Lu J; Ma X; Wang J; Jiang F; Tang S; Bao Y; Xiang K; Jia W
    PLoS One; 2010 Jul; 5(7):e11761. PubMed ID: 20668700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide interaction with the insulin secretion locus MTNR1B reveals CMIP as a novel type 2 diabetes susceptibility gene in African Americans.
    Keaton JM; Gao C; Guan M; Hellwege JN; Palmer ND; Pankow JS; Fornage M; Wilson JG; Correa A; Rasmussen-Torvik LJ; Rotter JI; Chen YI; Taylor KD; Rich SS; Wagenknecht LE; Freedman BI; Ng MCY; Bowden DW
    Genet Epidemiol; 2018 Sep; 42(6):559-570. PubMed ID: 29691896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells.
    Stumpf I; Mühlbauer E; Peschke E
    J Pineal Res; 2008 Oct; 45(3):318-27. PubMed ID: 18363673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New evidence for a role of melatonin in glucose regulation.
    Peschke E; Mühlbauer E
    Best Pract Res Clin Endocrinol Metab; 2010 Oct; 24(5):829-41. PubMed ID: 21112029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and clinical aspects of melatonin and clock genes in diabetes.
    Peschke E; Bähr I; Mühlbauer E
    J Pineal Res; 2015 Aug; 59(1):1-23. PubMed ID: 25904189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common variant in TFB1M is associated with reduced insulin secretion and increased future risk of type 2 diabetes.
    Koeck T; Olsson AH; Nitert MD; Sharoyko VV; Ladenvall C; Kotova O; Reiling E; Rönn T; Parikh H; Taneera J; Eriksson JG; Metodiev MD; Larsson NG; Balhuizen A; Luthman H; Stančáková A; Kuusisto J; Laakso M; Poulsen P; Vaag A; Groop L; Lyssenko V; Mulder H; Ling C
    Cell Metab; 2011 Jan; 13(1):80-91. PubMed ID: 21195351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of melatonin &MTNR1B variants with type 2 diabetes in Gujarat population.
    Patel R; Rathwa N; Palit SP; Ramachandran AV; Begum R
    Biomed Pharmacother; 2018 Jul; 103():429-434. PubMed ID: 29674279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.
    Bouatia-Naji N; Bonnefond A; Cavalcanti-Proença C; Sparsø T; Holmkvist J; Marchand M; Delplanque J; Lobbens S; Rocheleau G; Durand E; De Graeve F; Chèvre JC; Borch-Johnsen K; Hartikainen AL; Ruokonen A; Tichet J; Marre M; Weill J; Heude B; Tauber M; Lemaire K; Schuit F; Elliott P; Jørgensen T; Charpentier G; Hadjadj S; Cauchi S; Vaxillaire M; Sladek R; Visvikis-Siest S; Balkau B; Lévy-Marchal C; Pattou F; Meyre D; Blakemore AI; Jarvelin MR; Walley AJ; Hansen T; Dina C; Pedersen O; Froguel P
    Nat Genet; 2009 Jan; 41(1):89-94. PubMed ID: 19060909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.